Description
HiCel SMCC, is a unique combination of microcrystalline cellulose (MCC) and colloidal silicon dioxide (CSD). A high-functionality excipient requires less complex processing, has high inherent functionality, and passes that functionality on to the drug formulation. It is manufactured through co-process technology. Co-processing technology improves physical properties i.e. bulk density, flowability, and particle size of the blend thereby enabling to deliver good quality final product, a tablet. HiCel SMCC has outstanding flow properties. It delivered good tablets with 20-30% more tablet hardness in comparative to normal MCC. Outstanding flowability improves weight uniformity and dissolution profile. HiCel SMCC is a suitable binder filler for Pharmaceutical and Nutraceutical OSD formulations.
When used for direct compression, HiCel SMCC can replace granulations, while significantly reducing the number of required excipients and use levels. HiCel SMCC formulations produce distinctive, uniform, and cost-effective tablets.
Benefits of using HiCel SMCC:
• Outstanding Flow
• Excellent compatibility
• Enhanced lubrication efficiency
• Improved blending properties
• Dust-free handling during production
• Increased production capacity

















































